Piramal Enterprises is set to raise ₹2,000 crore through the issuance of Non-Convertible Debentures (NCDs). The Piramal Group, a global conglomerate with operations in pharmaceuticals, financial services, and real estate, spans over 30 countries and employs more than 10,000 people worldwide. The board of Piramal Enterprises has approved a plan to issue NCDs with a face value of ₹1,000 each, in one or more phases, to raise up to ₹2,000 crore. Piramal Enterprises’ shares closed at ₹1,090.25 on the NSE. Over the past year, the stock has delivered a 23% return, while its 2024 performance stands at 17%, outperforming the Nifty, which has gained 11% over the last 12 months. Year-to-date, the Nifty has risen by 8%. For Q2FY25, Piramal Enterprises reported consolidated revenue of ₹2,302.9 crore, an increase from ₹1,960.6 crore during the same period last year. The company posted a net profit of ₹22.6 crore, significantly higher than the ₹5 crore reported in Q2FY24.